Yilong Xi

机构：China Pharmaceutical University · ORCID：0009-0004-1943-5829

发表论文 8 篇 · 总被引 179 次 · h-index 5

代表论文

Lipoprotein-Inspired Nanoscavenger for the Three-Pronged Modulation of Microglia-Derived Neuroinflammation in Alzheimer’s Disease Therapy (2022 · Nano Letters · 被引 65)
High-density lipoprotein in Alzheimer's disease: From potential biomarkers to therapeutics (2021 · Journal of Controlled Release · 被引 36)
Sponge particulates for biomedical applications: Biofunctionalization, multi-drug shielding, and theranostic applications (2021 · Biomaterials · 被引 30)
Versatile nanomaterials for Alzheimer's disease: Pathogenesis inspired disease-modifying therapy (2022 · Journal of Controlled Release · 被引 26)
Nasal delivery of polymeric nanoDisc mobilizes a synergy of central and peripheral amyloid-β clearance to treat Alzheimer’s disease (2023 · Proceedings of the National Academy of Sciences · 被引 18)
Pathology-directed drug delivery strategies: How to overcome blood–brain barrier for the treatment of brain diseases (2025 · Acta Pharmaceutica Sinica B · 被引 4)